Literature DB >> 2836713

"Transformation" of human endothelial cells by SV40 virions.

H Ide1, Y Minamishima, Y Eizuru, M Okada, K Sakihama, T Katsuki.   

Abstract

Human endothelial cells derived from the umbilical vein were transformed with SV40 virions. A cell line subcultured for over 60 serial passages was characterized in comparison with its untransformed counterpart which was culturable for less than five passages. The SV40-transformed human endothelial cells, designated SV-HUVEC, were positive not only for tumor (T) antigen specific to the SV40-transformed cell, but also for two markers of endothelial cells, Factor VIII-related antigen and a receptor for Ulex europaeus agglutinin I. By transformation the growth potential of the human endothelial cells was increased and their serum requirement was decreased. The SV40-transformed endothelial cells were, however, unable to form colonies in soft agar or to form tumors in athymic nude mice, although a small nodule was produced at the site of inoculation. Subcultivation of these cells up to the 62nd passage eventually resulted in crisis and loss of further cell division. Thus, the human endothelial cells were transformed by SV40 while retaining certain normal functions but without showing tumorigenicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836713     DOI: 10.1111/j.1348-0421.1988.tb01364.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  2 in total

1.  Lysosomal glycosphingolipid storage in chloroquine-induced alpha-galactosidase-deficient human endothelial cells with transformation by simian virus 40: in vitro model of Fabry disease.

Authors:  M Inagaki; T Katsumoto; E Nanba; K Ohno; S Suehiro; K Takeshita
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

2.  Isolation of Primary Mouse Pulmonary Microvascular Endothelial Cells and Generation of an Immortalized Cell Line to Obtain Sufficient Extracellular Vesicles.

Authors:  Xu Liu; Feiping Xia; Xiao Wu; Ying Tang; Lu Wang; Qin Sun; Ming Xue; Wei Chang; Ling Liu; Fengmei Guo; Yi Yang; Haibo Qiu
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.